We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$24.6B
AUM Growth
+$2.47B
(+11%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
25.43%
Holding
1,038
New
49
Increased
357
Reduced
452
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$131M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$116M |
| 3 |
Visa
V
|
+$111M |
| 4 |
Home Depot
HD
|
+$85.9M |
| 5 |
S&P Global
SPGI
|
+$82.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$43M |
| 2 |
West Pharmaceutical
WST
|
+$42.6M |
| 3 |
Church & Dwight Co
CHD
|
+$40.9M |
| 4 |
Fair Isaac
FICO
|
+$39.7M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.11% |
| 2 | Financials | 13.59% |
| 3 | Healthcare | 12.97% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Gilead Sciences
GILD
$166B
| $60.7M | 0.25% |
787,185
+68,380
| +10% | +$5.45M |
|
77
Willis Towers Watson
WTW
$30B
| $60.2M | 0.25% |
255,626
-22,223
| -8% | -$5.12M |
|
78
Lam Research
LRCX
$322B
| $59.3M | 0.24% |
921,990
+316,660
| +52% | +$17.8M |
|
79
Boeing
BA
$168B
| $57.9M | 0.24% |
274,062
+186,069
| +211% | +$38.7M |
|
80
Wells Fargo
WFC
$258B
| $57.8M | 0.24% |
1,354,673
+300,873
| +29% | +$12.1M |
|
81
Equinix
EQIX
$99.7B
| $56.5M | 0.23% |
72,018
+14,173
| +25% | +$10.4M |
|
82
Qualcomm
QCOM
$169B
| $56M | 0.23% |
470,496
-3,761
| -0.8% | -$432K |
|
83
Royal Bank of Canada
RY
$289B
| $55.8M | 0.23% |
583,396
+173,313
| +42% | +$16.5M |
|
84
TSMC
TSM
$1.97T
| $55.7M | 0.23% |
551,438
+207,377
| +60% | +$19.3M |
|
85
Zoetis
ZTS
$32.8B
| $54.3M | 0.22% |
315,386
-17,321
| -5% | -$2.99M |
|
86
United Parcel Service
UPS
$89.2B
| $53.2M | 0.22% |
296,679
-18,587
| -6% | -$3.3M |
|
|
87
Fair Isaac
FICO
$32.4B
| $52.4M | 0.21% |
64,754
-52,896
| -45% | -$39.7M |
|
88
Hubbell
HUBB
$24.2B
| $50.7M | 0.21% |
153,035
-36,137
| -19% | -$10M |
|
89
IBM
IBM
$215B
| $50.6M | 0.21% |
377,887
+213,265
| +130% | +$27.5M |
|
90
Nike
NKE
$63.2B
| $50.4M | 0.21% |
456,560
+44,525
| +11% | +$5.21M |
|
91
Canadian National Railway
CNI
$78.3B
| $49.6M | 0.2% |
409,322
+175,576
| +75% | +$20.8M |
|
92
Alcon
ALC
$33.9B
| $49.6M | 0.2% |
598,881
+129,988
| +28% | +$9.93M |
|
93
Xylem
XYL
$28.6B
| $49.3M | 0.2% |
437,405
-56,780
| -11% | -$6M |
|
94
Automatic Data Processing
ADP
$111B
| $49.1M | 0.2% |
223,402
+27,993
| +14% | +$6.04M |
|
95
Air Products & Chemicals
APD
$65.6B
| $48.9M | 0.2% |
163,395
-87,388
| -35% | -$24.9M |
|
96
Cigna
CI
$78.9B
| $48.6M | 0.2% |
173,190
+54,917
| +46% | +$14.3M |
|
97
Morgan Stanley
MS
$324B
| $47.7M | 0.19% |
558,885
+211,275
| +61% | +$18.1M |
|
98
Alibaba
BABA
$277B
| $47.6M | 0.19% |
570,847
-12,140
| -2% | -$1.06M |
|
99
Target
TGT
$66.7B
| $46.9M | 0.19% |
355,349
+14,936
| +4% | +$2.22M |
|
100
GE Aerospace
GE
$366B
| $45.5M | 0.19% |
519,310
+467,011
| +893% | +$37.8M |
|
Similar funds
QCM
NAMI
Aviva's Q2 2023 Portfolio in Review
As of Q2 2023, Aviva held 1,038 positions worth $24.6B, up 11% from $22.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Aviva's Q2 2023 filing shows 49 new, 357 increased, 452 reduced and 75 closed positions. Its largest new stake was ATS Corp: 438,979 shares worth $20.2M. The largest sale was Marathon Petroleum, an estimated $43M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- Aviva's largest Q2 2023 buy was ATS Corp: 438,979 shares worth $20.2M.
- Aviva added most to ExxonMobil in Q2 2023, an estimated $131M increase.
- Aviva's biggest Q2 2023 reduction was Marathon Petroleum, cutting an estimated $43M.
- Aviva fully exited United Therapeutics in Q2 2023, selling an estimated $20.4M.
- Aviva's ten largest holdings make up 25% of its $24.6B portfolio in Q2 2023.
- Aviva opened 49 new positions and closed 75 in Q2 2023.
- Aviva's portfolio value rose 11% quarter-over-quarter to $24.6B.
Based on Aviva's 13F filing for Q2 2023, filed 10 Aug 2023.